Abstract Submission

Abstract Guidelines

Abstract Title

• Should be sentence case (i.e., only the first letter of the title should be capitalized)
• Should be plain text (No html)
• Word Limit: 75 words/ 200 characters

Abstract Body

• Word Limit: 450 words
• Figures and tables are not allowed
• Should be in a single paragraph
• If subheaders are used, they should be within that single paragraph in all-caps, not bolded (e.g., METHODS:)
• If you use the greater than/equal to symbol, you MUST put a space before entering the number.
• Abstracts should be data-driven and must include this information in the body of the abstract.
• Please be sure to carefully check your abstract for content errors, spelling, names, etc. before submitting. IPBIS neither proofreads for nor corrects spelling, typographical, grammatical, or scientific errors.

Authors

• There can only be 1 presenting author per submission.
• There is a maximum of 50 co-authors per abstract submission.
• Enter the names of authors in the order in which you wish them to appear in the printed text.
• The name used in the abstract submission will be displayed as the presenter in the online agenda.
• Emails sent by IPBIS to abstract presenters will be sent to the email address provided in the abstract submission.
• It is the responsibility of that recipient to ensure that the actual presenter receives all communications from the time of submission until after the conference.
• Presenting authors will be required to register if accepted.

General Guidelines

• Please make sure your abstract contains only generic drugs names. Abstracts with trade names in the title or body could be precluded from presentation.
• Please be sure to carefully check your submission for content errors. IPBIS neither proofreads for nor corrects spelling, typographical, grammatical, or scientific errors. Errors made on your submitted abstract are likely to appear in print.
• Please be sure to verify the presenters email address. All communication regarding the abstract will be sent to the presenting author’s email address that was entered at the time of submission.

Registration Requirements

If your abstract is accepted for presentation at the meeting in Glasgow, the presenting author is required to register for the meeting by the presenter registration deadline. If the presenting author does not register for the meeting in Glasgow by this deadline, their abstract will be withdrawn from the program. Additional registration details will be provided in the acceptance email.

Abstract Submission Categories

IPBIS welcomes educational and research abstracts on the topics listed below.

• Acquired brain injury assessments
• Acute acquired brain injury care and treatment
• Age at injury and gender effects on outcomes
• Cognitive and communication issues and rehabilitation
• Community rehabilitation
• Complementary and alternative treatments
• Concussion and mTBI
• Developmental issues through childhood, adolescence and young adulthood
• Disorders of consciousness
• Family supports and interventions and lived experience
• Legal issues relating to ABI personal injury claims
• Life-long and chronic issues
• Management of sleep disturbance and of fatigue in acute and longer-term ABI
• Medical complications of brain injury and long-term medical concerns and interventions
• Non-accidental head trauma  
• Non-traumatic ABI, including stroke, neuro-oncology, infections etc
• Outcome measurement in acute brain injury care and rehabilitation
• Physical rehabilitation and posture management
• Prevention
• Psychiatric/mental health issues after brain injury and dual diagnosis issues, i.e. mental health and ABI diagnosis and treatment
• School/educational issues and rehabilitation
• Technology in rehabilitation

The abstract portal is now open!  Abstract submission deadline: 15 April, 2024.